BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 37942323)

  • 21. Aging, inflammation, immunity and periodontal disease.
    Ebersole JL; Graves CL; Gonzalez OA; Dawson D; Morford LA; Huja PE; Hartsfield JK; Huja SS; Pandruvada S; Wallet SM
    Periodontol 2000; 2016 Oct; 72(1):54-75. PubMed ID: 27501491
    [TBL] [Abstract][Full Text] [Related]  

  • 22. COVID-19 and Crosstalk With the Hallmarks of Aging.
    Salimi S; Hamlyn JM
    J Gerontol A Biol Sci Med Sci; 2020 Sep; 75(9):e34-e41. PubMed ID: 32544216
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Role of Immunosenescence in the Development of Age-Related Diseases.
    Fülöp T; Dupuis G; Witkowski JM; Larbi A
    Rev Invest Clin; 2016; 68(2):84-91. PubMed ID: 27103044
    [TBL] [Abstract][Full Text] [Related]  

  • 24. cGAS-STING pathway as a potential trigger of immunosenescence and inflammaging.
    Schmitz CRR; Maurmann RM; Guma FTCR; Bauer ME; Barbé-Tuana FM
    Front Immunol; 2023; 14():1132653. PubMed ID: 36926349
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Contributions of Age-Related Thymic Involution to Immunosenescence and Inflammaging.
    Thomas R; Wang W; Su DM
    Immun Ageing; 2020; 17():2. PubMed ID: 31988649
    [TBL] [Abstract][Full Text] [Related]  

  • 26. COVID-19 and Brain Aging: What are the Implications of Immunosenescence?
    Keller GS; Medeiros EB; Dos Santos MLC; Lidio AV; Kucharska E; Budni J
    Curr Aging Sci; 2023; 16(2):89-96. PubMed ID: 36579393
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inflammaging at the Time of COVID-19.
    Zazzara MB; Bellieni A; Calvani R; Coelho-Junior HJ; Picca A; Marzetti E
    Clin Geriatr Med; 2022 Aug; 38(3):473-481. PubMed ID: 35868667
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thymic Aging May Be Associated with COVID-19 Pathophysiology in the Elderly.
    Wang W; Thomas R; Oh J; Su DM
    Cells; 2021 Mar; 10(3):. PubMed ID: 33808998
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Down syndrome, accelerated aging and immunosenescence.
    Gensous N; Bacalini MG; Franceschi C; Garagnani P
    Semin Immunopathol; 2020 Oct; 42(5):635-645. PubMed ID: 32705346
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Circulating biomarkers of inflammaging as potential predictors of COVID-19 severe outcomes.
    Sabbatinelli J; Matacchione G; Giuliani A; Ramini D; Rippo MR; Procopio AD; Bonafè M; Olivieri F
    Mech Ageing Dev; 2022 Jun; 204():111667. PubMed ID: 35341896
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immune system modulation in aging: Molecular mechanisms and therapeutic targets.
    Cisneros B; García-Aguirre I; Unzueta J; Arrieta-Cruz I; González-Morales O; Domínguez-Larrieta JM; Tamez-González A; Leyva-Gómez G; Magaña JJ
    Front Immunol; 2022; 13():1059173. PubMed ID: 36591275
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunosenescence as a convergence pathway in neurodegeneration.
    Mohapatra L; Mishra D; Shiomurti Tripathi A; Kumar Parida S
    Int Immunopharmacol; 2023 Aug; 121():110521. PubMed ID: 37385122
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inflammaging and Immunosenescence as Part of Skin Aging-A Narrative Review.
    Pająk J; Nowicka D; Szepietowski JC
    Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175491
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Senescent cell-derived extracellular vesicles as potential mediators of innate immunosenescence and inflammaging.
    Hanley S; Chen YY; Hazeldine J; Lord JM
    Exp Gerontol; 2024 Mar; 187():112365. PubMed ID: 38237747
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aged brain and neuroimmune responses to COVID-19: post-acute sequelae and modulatory effects of behavioral and nutritional interventions.
    Müller L; Di Benedetto S
    Immun Ageing; 2023 Apr; 20(1):17. PubMed ID: 37046272
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The interplay between immunosenescence and age-related diseases.
    Barbé-Tuana F; Funchal G; Schmitz CRR; Maurmann RM; Bauer ME
    Semin Immunopathol; 2020 Oct; 42(5):545-557. PubMed ID: 32747977
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Should we Try to Alleviate Immunosenescence and Inflammaging - Why, How and to What Extent?
    Witkowski JM; Bryl E; Fulop T
    Curr Pharm Des; 2019; 25(39):4154-4162. PubMed ID: 31713479
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunosenescence and inflamm-ageing in COVID-19.
    Zinatizadeh MR; Zarandi PK; Ghiasi M; Kooshki H; Mohammadi M; Amani J; Rezaei N
    Ageing Res Rev; 2023 Feb; 84():101818. PubMed ID: 36516928
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The emerging roles and therapeutic implications of immunosenescence-mediated inflammaging in age-related hearing loss.
    Qiu K; Mao M; Pang W; Deng D; Ren J; Zhao Y
    Am J Stem Cells; 2024; 13(2):101-109. PubMed ID: 38765806
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunosenescence, inflammaging, and cancer immunotherapy efficacy.
    Rodriguez JE; Naigeon M; Goldschmidt V; Roulleaux Dugage M; Seknazi L; Danlos FX; Champiat S; Marabelle A; Michot JM; Massard C; Besse B; Ferrara R; Chaput N; Baldini C
    Expert Rev Anticancer Ther; 2022 Sep; 22(9):915-926. PubMed ID: 35815381
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.